Fairmount Funds Management’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213M Buy
2,537,191
+400,000
+19% +$23.2M 15.38% 2
2025
Q4
$88.1M Sell
2,137,191
-1,170,000
-35% -$45.4M 6.7% 6
2025
Q3
$130M Buy
3,307,191
+600,000
+22% +$15.3M 11.71% 1
2025
Q2
$50.4M Buy
2,707,191
+6,500
+0.2% +$122K 6.53% 7
2025
Q1
$49M Hold
2,700,691
7.6% 6
2024
Q4
$58.9M Hold
2,700,691
5.85% 9
2024
Q3
$73.9M Sell
2,700,691
-62,146
-2% -$1.73M 6% 9
2024
Q2
$71.5M Hold
2,762,837
8.08% 6
2024
Q1
$82.9M Buy
2,762,837
+834,334
+43% +$18.1M 9.03% 4
2023
Q4
$20.1M Hold
1,928,503
2.12% 12
2023
Q3
$26.4M Buy
+1,928,503
New +$24.3M 3.17% 13

Other funds holding DNTH